《奇正~?消痛贴膏临床应用专家共识》编制说明
|
摘要
奇正~?消痛贴膏是根据藏医传统验方采用现代制药技术研制的外用贴膏,具有活血化瘀、消肿止痛作用。自1993年上市以来,广泛应用于各类急慢性骨骼、肌肉疼痛及各类脊柱、关节、软组织病变的治疗。为了更好地规范奇正~?消痛贴膏的临床应用,提高临床疗效,2017年10月19日由中华中医药学会立项,中华中医药学会外治分会开展了《奇正~?消痛贴膏临床应用专家共识》的研制工作。该文将对奇正~?消痛贴膏专家共识的主要研制流程及相关技术环节进行总结,以便于广大医务工作者准确理解和应用,也可为中药外用药临床应用专家共识的研制提供参考。
As a topical plaster developed by modern pharmaceutical technology based on traditional Tibetan medicine,Cheezheng Xiaotong Tiegao has functions of promoting blood circulation,relieving swelling and relieving pain. Since its introduction in 1993,it has been widely used in the treatment of various types of acute and chronic musculoskeletal pain and various types of spinal,joint and soft tissue diseases. In order to better standardize the clinical application and improve the clinical efficacy of Cheezheng Xiaotong Tiegao,the research and development work of the Experts consensus statement on Cheezheng Xiaotong Tiegao in clinical practice was officially launched on October 19,2017,upon approval from China Association of Chinese Medicine. In this paper,main R&D process and related technical links for the experts consensus on Cheezheng Xiaotong Tiegao would be summarized,which will help the various medical workers understand,master and apply more accurately,and also provide reference for the development of experts consensus on clinical application of other topical Chinese medicines.
As a topical plaster developed by modern pharmaceutical technology based on traditional Tibetan medicine,Cheezheng Xiaotong Tiegao has functions of promoting blood circulation,relieving swelling and relieving pain. Since its introduction in 1993,it has been widely used in the treatment of various types of acute and chronic musculoskeletal pain and various types of spinal,joint and soft tissue diseases. In order to better standardize the clinical application and improve the clinical efficacy of Cheezheng Xiaotong Tiegao,the research and development work of the Experts consensus statement on Cheezheng Xiaotong Tiegao in clinical practice was officially launched on October 19,2017,upon approval from China Association of Chinese Medicine. In this paper,main R&D process and related technical links for the experts consensus on Cheezheng Xiaotong Tiegao would be summarized,which will help the various medical workers understand,master and apply more accurately,and also provide reference for the development of experts consensus on clinical application of other topical Chinese medicines.
引文
[1]方赛男,郭宇博,刘建平,等.中成药临床应用专家共识的制订流程[J].中国中药杂志,2018,43(24):4786.
[2]莫美,张霄潇,廖星,等.中华中医药学会中成药临床应用专家共识编制说明编写规范[J].中国中药杂志,2019,44(12):2652.
[3]温建民,童培建,詹红生,等.奇正消痛贴膏临床应用专家共识[J].中国中药杂志,2019,44(4):629.
[4]国家中医药管理局.国家基本药物目录2018年版[EB/OL].(2018-10-25)[2019-02-25]. http://www. nhfpc. gov. cn/yaozs/s7656/201810/c18533e22a3940d08d996b588d941631.shtml.
[5]中国药典.一部[S]. 2015.
[6]中华人民共和国人力资源社会保障部.国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)[EB/OL].(2017-02-21)[2019-02-25]. http://www. mohrss. gov. cn/SYrlzyhshbzb/shehuibaozhang/zcwj/201702/t20170223_266775.html.
[7]方赛男,孙塑伦,郭宇博,等.中成药临床应用专家共识制订有关问题讨论[J].中国中药杂志,2018,43(24):4792.
[8] GRADE pro G D T. GRADEpro guideline development tool[EB/OL].(2018-12-14)[2019-02-25]. https://gradepro.org/.
[2]莫美,张霄潇,廖星,等.中华中医药学会中成药临床应用专家共识编制说明编写规范[J].中国中药杂志,2019,44(12):2652.
[3]温建民,童培建,詹红生,等.奇正消痛贴膏临床应用专家共识[J].中国中药杂志,2019,44(4):629.
[4]国家中医药管理局.国家基本药物目录2018年版[EB/OL].(2018-10-25)[2019-02-25]. http://www. nhfpc. gov. cn/yaozs/s7656/201810/c18533e22a3940d08d996b588d941631.shtml.
[5]中国药典.一部[S]. 2015.
[6]中华人民共和国人力资源社会保障部.国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)[EB/OL].(2017-02-21)[2019-02-25]. http://www. mohrss. gov. cn/SYrlzyhshbzb/shehuibaozhang/zcwj/201702/t20170223_266775.html.
[7]方赛男,孙塑伦,郭宇博,等.中成药临床应用专家共识制订有关问题讨论[J].中国中药杂志,2018,43(24):4792.
[8] GRADE pro G D T. GRADEpro guideline development tool[EB/OL].(2018-12-14)[2019-02-25]. https://gradepro.org/.